Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: A Randomized Controlled Trial on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy in Subjects With Moderate to Severe Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 randomized trial assessing safety and efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for moderate to severe diabetic peripheral neuropathy; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cell Therapy (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Min Long | Conditions: Diabetic Peripheral Neuropathy (DPN) | Phase 2 | Status: RECRUITING